UNSPSC 85877420: Fluoroscopy of left ureter using high osmolar contrast

This classification denotes the group of activities that yields a imaging intervention or procedure to fluoroscopy of left ureter using high osmolar contrast. This intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code BT170ZZ

UNSPSC 85877420 Fluoroscopy of left ureter using high osmolar contrast is a Commodity code that shows minimal direct alignment with recent state and local procurement activity. The nominal scope—a specific radiologic diagnostic procedure—does not match the actual work being solicited under this code tag in current opportunities. Recent solicitations classified under 85877420 span diagnostic imaging infrastructure (picture archiving and communication systems), ultrasound equipment procurement, and clinical laboratory services (phlebotomy), none of which represent fluoroscopy procedures or high osmolar contrast media. The issuing bodies include a county hospital system (San Mateo Medical Center), a county procurement division on behalf of health services (Collier County, Florida), and a city police department's scientific evidence unit (Albuquerque Police Department), suggesting the code may be tagged broadly across health system and public-safety diagnostic service categories rather than reserved for a specific procedural billing or inventory line.

The geographic spread of recent activity spans California (San Mateo County), Florida (Collier County), and New Mexico (Albuquerque), with no clear concentration pattern. Representative recent opportunities include San Mateo Medical Center's RFP for a Diagnostic Imaging PACS system with proposals due August 7, 2026, supporting enterprise radiology, cardiology, and dental imaging workflows; Collier County's Notice of Intent to single-source EchoNous ultrasound equipment and related services (posted April 1, 2026); and Albuquerque Police Department's RFB for on-call blood draw services with bids due February 25, 2026. The code's current tagging appears to reflect a mislabeling of broader diagnostic and laboratory service procurement rather than genuine fluoroscopy-specific demand, reducing relevance for vendors focused on this specific imaging modality or contrast media.